Amy Schacterle serves as Chief Regulatory Officer at Acumen Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Amy Schacterle has executed 3 insider transactions totaling $2.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 16, 2026 involved receiving (via award) 126,900 shares valued at $0.
Amy Schacterle currently holds 126,900 shares of Acumen Pharmaceuticals, Inc. (ABOS), valued at approximately $0. This represents their equity stake as Chief Regulatory Officer.
Based on SEC Form 4 filings, Amy Schacterle has been a net seller of ABOS stock. They have purchased $0 and sold $2.2K worth of shares.
Amy Schacterle's most recent insider trade was on Jan 16, 2026, when they sold 126,900 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 7, 2026 | ABOS | $2.2K | Sale | 1,097 | $1.98 | Discretionary |